Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | COMT | P21964 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4652231 | 0.99 | CYP1A2 (0.49) | CYP1A2CYP2C19KAT2BKDM4EL3MBTL1 | |
| SCHEMBL4150453 | 0.91 | CYP1A2 (0.54) | CYP1A2CYP2C19KAT2BKDM4EL3MBTL1 | |
| SCHEMBL13943471 | 0.86 | CYP1A2 (0.50) | CYP1A2CYP2C19KAT2BKDM4EL3MBTL1 | |
| SCHEMBL13943867 | 0.84 | CYP1A2 (0.48) | CYP1A2CYP2C19KAT2BKDM4EL3MBTL1 | |
| SCHEMBL14270412 | 0.84 | CYP1A2 (0.47) | CYP1A2CYP2C19KAT2BKDM4EL3MBTL1 | |
| SCHEMBL13943866 | 0.84 | CYP1A2 (0.47) | CYP1A2CYP2C19KAT2BKDM4EL3MBTL1 | |
| SCHEMBL4162838 | 0.84 | CYP1A2 (0.47) | CYP1A2CYP2C19KAT2BKDM4EL3MBTL1 | |
| SCHEMBL4150996 | 0.83 | CYP1A2 (0.51) | CYP1A2CYP2C19KAT2BL3MBTL1LMNA | |
| SCHEMBL13943483 | 0.83 | CYP1A2 (0.46) | CYP1A2CYP2C19KAT2BKDM4EL3MBTL1 | |
| SCHEMBL13943886 | 0.82 | CYP1A2 (0.44) | CYP1A2CYP2C19KAT2BKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1973908-A2 | PROCESSES AND INTERMEDIATES USEFUL FOR PREPARING INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2008-10-01 | — | — | EP | disclosed |
| EP-1888581-A2 | HIV-INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2008-02-20 | — | — | EP | disclosed |
| US-20080039487-A1 | Processes and intermediates useful for preparing integrase inhibitor compounds | GILEAD SCIENCES, LLC | 2008-02-14 | — | — | US | disclosed |
| US-20080039487-A1 | Processes and intermediates useful for preparing integrase inhibitor compounds | GILEAD SCIENCES, LLC | 2008-02-14 | — | — | US | disclosed |
| US-20080039487-A1 | Processes and intermediates useful for preparing integrase inhibitor compounds | GILEAD SCIENCES, LLC | 2008-02-14 | — | — | US | disclosed |
| WO-2007076005-A2 | PROCESSES AND INTERMEDIATES USEFUL FOR PREPARING INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007076005-A2 | PROCESSES AND INTERMEDIATES USEFUL FOR PREPARING INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
| US-20070072831-A1 | Integrase inhibitor compounds | GILEAD SCIENCES, INC. | 2007-03-29 | — | — | US | disclosed |
| US-20070072831-A1 | Integrase inhibitor compounds | GILEAD SCIENCES, INC. | 2007-03-29 | — | — | US | disclosed |
| US-20070072831-A1 | Integrase inhibitor compounds | GILEAD SCIENCES, INC. | 2007-03-29 | — | — | US | disclosed |
| WO-2006125048-A2 | HIV-INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070072831-A1 | Integrase inhibitor compounds | TYMP, CDKN1A, PAICS | CYP1A2 1685/4885CYP2C19 1140/4885KAT2B 899/4885 |
| US-20080039487-A1 | Processes and intermediates useful for preparing integrase inhibitor compounds | TYMP, DUT, SAMHD1 | CYP1A2 686/4885CYP2C19 349/4885KAT2B 2463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.